| |
|
|
|
Leap Therapeutics Inc  
|
|
1.59 0.09 (0.06%) |
11-27 13:00 |
|
Open: |
1.51 |
Pre close: |
1.5 |
Target:
|
2.28
|
|
High: |
1.62 |
Low: |
1.5005 |
Resistance:
|
1.96
2.28
|
|
Volume: |
791,378 |
Market Cap: |
95M |
Support:
|
1.43
1.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.51
 |
MACD |
MACD(12,26):
|
-0.12 |
|
MA(20): |
1.67  |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
1.90 |
Stochastic Oscillator |
%K(14,3):
|
11.37 |
|
MA(250): |
1.89 |
%D(3): |
8.25 |
|
Average Volume(K) |
3-Month: |
59963
|
52-Week |
High:
|
3.18 |
|
10-Days: |
65286 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
42.49 |
Change(%): |
115.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-3.160 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-3.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.630 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-1.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.502 |
P/E |
0.00 |
|
Sales Per Share |
0.013 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
126.48 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
